Kjell E. Oberg

Kjell E. Oberg

Uppsala, C 75236, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 123 publications

A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires.

A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires.

Journal: Journal of clinical medicine

Published: January 22, 2022

ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours.

ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours.

Journal: Journal of neuroendocrinology

Published: July 28, 2021

A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility.

A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 28, 2021

Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series.

Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series.

Journal: Asia-Pacific journal of clinical oncology

Published: December 08, 2020

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 24, 2020

Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment.

Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment.

Journal: World journal of gastroenterology

Published: November 23, 2020

NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis.

NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis.

Journal: Endocrine connections

Published: November 22, 2020

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 10, 2020

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 10, 2020

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma.

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma.

Journal: Upsala journal of medical sciences

Published: October 12, 2020

Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest).

Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest).

Journal: Annals of surgical oncology

Published: October 09, 2020

Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.

Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.

Journal: Neuroendocrinology

Published: October 07, 2020

Showing 1-12 of 123

Last Updated: 09/26/2026